Catapres and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Catapres (clonidine hydrochloride) and Atorvastatin calcium (atorvastatin calcium). Common drug interactions include blood urea increased among females and adverse event among males.

The phase IV clinical study analyzes what interactions people have when they take Catapres and Atorvastatin calcium. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Catapres?

Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

On Jul, 19, 2026

23 people who take Catapres and Atorvastatin calcium together, and have interactions are studied.

Catapres and Atorvastatin calcium drug interactions.

What are the common drug interactions of Catapres and Atorvastatin Calcium, by gender? *:

female:

Blood urea increased
Cachexia (loss of weight)
Globulins decreased
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
Hypersomnia (excessive daytime sleepiness (eds))
Iron binding capacity total decreased
Nausea (feeling of having an urge to vomit)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Nerve compression
Oedema peripheral (superficial swelling)

male:

Adverse event
Back pain
Hypoaesthesia (reduced sense of touch or sensation)
Nephrogenic anaemia (anaemia due to kidney disease)
Pain
Pneumonia
Renal failure (kidney dysfunction)
Abdominal discomfort
Abdominal pain
Acute respiratory failure

What are the common drug interactions of Catapres and Atorvastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood pressure systolic decreased
Overdose

50-59:

Adverse event
Back pain
Blood pressure decreased
Infusion related reaction
Petechiae (a small red or purple spot caused by bleeding into the skin)
Abdominal discomfort
Acute respiratory failure
Anastomotic stenosis
Asthma
Balance disorder

60+:

Blood calcium decreased
Blood glucose increased
Cachexia (loss of weight)
Chronic kidney disease
Globulins decreased
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
Hypersomnia (excessive daytime sleepiness (eds))
Iron binding capacity total decreased
Nausea (feeling of having an urge to vomit)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 3 people, 13.04%
Pain: 2 people, 8.70%
Osteoporosis (bones weak and more likely to break): 2 people, 8.70%
Metastases To Breast (cancer spreads to brain): 2 people, 8.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Catapres and Atorvastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously